CYP 0.00% 26.0¢ cynata therapeutics limited

Your argument is all over the place. First you are disappointed...

  1. 834 Posts.
    lightbulb Created with Sketch. 339
    Your argument is all over the place. First you are disappointed that we hired someone to chase partners, but at the same time you are disappointed that Killian hasn’t gotten us any partners? You don’t get to eat your cake and have it too. Either you think we’re too far away from partnerships and the guy shouldn’t have been hired, in which case you have no reason to criticise Killian for not having signed a license agreement. Or we’re close and it makes sense to get someone with proven experience on board to secure the best deal/s for Cynata.

    If there is a sniff of a partner on the way for DFU (and we know from the webinar that multiple NDA’s have been signed), then the acquisition DID need to be made prior to that been finalised. I can’t explain it any clearer than this: complexity kills deals. Having ownership of the relevant IP is critical.

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.000(0.00%)
Mkt cap ! $46.70M
Open High Low Value Volume
26.0¢ 26.5¢ 26.0¢ $22.52K 86.65K

Buyers (Bids)

No. Vol. Price($)
1 34500 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 8292 2
View Market Depth
Last trade - 15.25pm 19/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.